Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Testosterone may both worsen and protect against COVID-19 effects in men.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Menopause affects hair and skin; more research needed for treatment.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Some common medications can harm male fertility, but many effects can be reversed.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.